Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Riccardo Saccardi

Showing results (1-10 of 139) with videos related to

Pageof 14
Sort By:
Handbook of Clinical Neurology|August 7, 2024
The role of chemotherapy in hematopoietic stem cell transplantation for autoimmune disorders: From lymphoablative to myeloablative conditioning protocolsAlice Mariottini, Riccardo Saccardi
The Lancet. Neurology|June 21, 2008
Autologous haematopoietic stem-cell transplantation in multiple sclerosisGianluigi Mancardi, Riccardo Saccardi
Autoimmunity|October 30, 2008
This issue reports the results of HSCT. Concluding remarksAlberto M Marmont, Riccardo Saccardi
Current Treatment Options in Neurology|May 3, 2013
Autologous hematopoietic stem cell transplantation as a treatment option for aggressive multiple sclerosisNikolai Pfender, Riccardo Saccardi, Roland Martin
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 30, 2012
HCT for nonmalignant disordersJohn F Tisdale, Mary Eapen, Riccardo Saccardi
Multiple Sclerosis and Related Disorders|August 12, 2023
Should autologous hematopoietic stem cell transplantation be offered as a first-line disease modifying therapy to patients with multiple sclerosis?Alice Mariottini, Paolo A Muraro, Riccardo Saccardi
Current Opinion in Hematology|October 4, 2008
Haematopoietic stem cell transplantation for autoimmune disordersRiccardo Saccardi, Massimo Di Gioia, Alberto Bosi
Multiple Sclerosis (Houndmills, Basingstoke, England)|May 22, 2016
NEDA status in highly active MS can be more easily obtained with autologous hematopoietic stem cell transplantation than other drugsMaria Pia Sormani, Paolo A Muraro, Riccardo Saccardi, et al.
Plos One|July 23, 2019
A non-traditional approach to cryopreservation by ultra-rapid cooling for human mesenchymal stem cellsTiziana Irdani, Benedetta Mazzanti, Lara Ballerini, et al.
The Journal of Rheumatology|December 1, 2004
High dose immunotherapy with stem cell rescue in severe systemic sclerosis: an idea that is moving forwardDaniel E Furst, Richard Nash, Keith M Sullivan, et al.
Pageof 14

Showing results (1-10 of 139) with videos related to

Sort By:
Pageof 14
Handbook of Clinical Neurology|August 7, 2024
The role of chemotherapy in hematopoietic stem cell transplantation for autoimmune disorders: From lymphoablative to myeloablative conditioning protocolsAlice Mariottini, Riccardo Saccardi
The Lancet. Neurology|June 21, 2008
Autologous haematopoietic stem-cell transplantation in multiple sclerosisGianluigi Mancardi, Riccardo Saccardi
Autoimmunity|October 30, 2008
This issue reports the results of HSCT. Concluding remarksAlberto M Marmont, Riccardo Saccardi
Current Treatment Options in Neurology|May 3, 2013
Autologous hematopoietic stem cell transplantation as a treatment option for aggressive multiple sclerosisNikolai Pfender, Riccardo Saccardi, Roland Martin
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 30, 2012
HCT for nonmalignant disordersJohn F Tisdale, Mary Eapen, Riccardo Saccardi
Multiple Sclerosis and Related Disorders|August 12, 2023
Should autologous hematopoietic stem cell transplantation be offered as a first-line disease modifying therapy to patients with multiple sclerosis?Alice Mariottini, Paolo A Muraro, Riccardo Saccardi
Current Opinion in Hematology|October 4, 2008
Haematopoietic stem cell transplantation for autoimmune disordersRiccardo Saccardi, Massimo Di Gioia, Alberto Bosi
Multiple Sclerosis (Houndmills, Basingstoke, England)|May 22, 2016
NEDA status in highly active MS can be more easily obtained with autologous hematopoietic stem cell transplantation than other drugsMaria Pia Sormani, Paolo A Muraro, Riccardo Saccardi, et al.
Plos One|July 23, 2019
A non-traditional approach to cryopreservation by ultra-rapid cooling for human mesenchymal stem cellsTiziana Irdani, Benedetta Mazzanti, Lara Ballerini, et al.
The Journal of Rheumatology|December 1, 2004
High dose immunotherapy with stem cell rescue in severe systemic sclerosis: an idea that is moving forwardDaniel E Furst, Richard Nash, Keith M Sullivan, et al.
Pageof 14